WINT

Windtree Therapeutics (WINT)

Windtree Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:WINT

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/04	21 : 00	GlobeNewswire Inc.	Windtree Completes Enrollment of Phase 2b Study of Istaroxime in Early Cardiogenic Shock	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/04	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/04	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/03	22 : 10	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/03	22 : 09	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/03	20 : 26	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/03	20 : 22	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/24	05 : 15	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/22	05 : 55	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/21	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/21	05 : 05	GlobeNewswire Inc.	Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/20	06 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/15	05 : 24	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/15	05 : 20	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/15	05 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/15	05 : 11	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/15	05 : 05	GlobeNewswire Inc.	Windtree Announces New Additions and Changes to Its Board of Directors	NASDAQ:WINT	Windtree Therapeutics Inc
2024/07/29	21 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/07/26	05 : 07	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:WINT	Windtree Therapeutics Inc
2024/07/25	21 : 00	GlobeNewswire Inc.	Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial Data	NASDAQ:WINT	Windtree Therapeutics Inc
2024/07/25	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:WINT	Windtree Therapeutics Inc
2024/07/25	06 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:WINT	Windtree Therapeutics Inc
2024/07/23	05 : 05	GlobeNewswire Inc.	Windtree Therapeutics Announces Closing of Financing Through a Private Placement of Series C Preferred Stock	NASDAQ:WINT	Windtree Therapeutics Inc
2024/07/22	22 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/07/11	05 : 53	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/05/16	05 : 59	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:WINT	Windtree Therapeutics Inc
2024/05/09	21 : 41	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:WINT	Windtree Therapeutics Inc
2024/05/07	21 : 00	GlobeNewswire Inc.	Windtree Therapeutics Regains Compliance with Nasdaq	NASDAQ:WINT	Windtree Therapeutics Inc
2024/04/18	21 : 00	GlobeNewswire Inc.	Windtree Therapeutics Announces Reverse Stock Split	NASDAQ:WINT	Windtree Therapeutics Inc
2024/04/17	21 : 00	GlobeNewswire Inc.	Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates	NASDAQ:WINT	Windtree Therapeutics Inc